Prevalence and Risk Factors of Preserved Ratio Impaired Spirometry in People With HIV and Matched Population Control Participants
CHEST · 2026-11 · 170 (5) · 1532-1542
DOI: 10.1016/j.chest.2026.05.044 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift CHEST, 2026-11. Verfasst von Safura-Luise Heidari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: HIV Infections, Spirometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Independent Research Fund Denmark, Gilead Sciences Inc, Copenhagen University Hospital Rigshospitalet.
Abstract (Originalsprache)
BACKGROUND: People with HIV (PWH) have a higher burden of respiratory comorbidities than the general population, yet emerging spirometry impairments such as preserved ratio impaired spirometry (PRISm) and restrictive spirometry patterns (RSPs) have received limited attention. RESEARCH QUESTION: Is HIV status associated with PRISm and RSP in well-treated PWH residing in high-income settings? STUDY DESIGN AND METHODS: In a cross-sectional study including 1,080 PWH from the Copenhagen Comorbidity in HIV Infection Study and 12,079 matched population control participants from the Copenhagen General Population Study, we examined the prevalence and explored the association between HIV status and PRISm and RSP. PRISm were defined as FEV1 to FVC ratio equal to or more than the lower limit of normal (LLN) and FEV1 less than the LLN, and RSP was defined as FEV1 to FVC equal to or more than the LLN and FVC less than the LLN. We used multivariable logistic regression analyses and adjusted for HIV-specific and traditional risk factors. RESULTS: The prevalence of PRISm and RSP was higher among PWH compared with population control participants (PRISm: 10.5% [95% CI, 8.8%-12.4%] vs 3.5% [95% CI, 3.2%-3.8%]; P < .01; RSP: 10.6% [95% CI, 8.9%-12.6%] vs 3.2% [95% CI, 2.9%-3.5%]; P < .01). These differences persisted in analyses restricted to people who never smoked. HIV was associated with PRISm and RSP in univariable analyses; in models adjusted for age, sex, smoking status, BMI, and educational level (PRISm: OR, 3.58 [95% CI, 2.77-4.63]; RSP: OR, 4.55 [95% CI, 3.51-5.91]), and in fully adjusted models with alcohol consumption, diabetes, and hypertension (PRISm: OR, 3.40 [95% CI, 2.59-4.47]; RSP: OR, 4.34 [95% CI, 3.29-5.73]). PWH with PRISm or RSP showed a higher burden of respiratory symptoms compared with those without. INTERPRETATION: PWH showed 3-fold higher prevalences of PRISm and RSP compared with population control participants, and HIV was associated independently with these lung function impairments. PRISm and RSP may represent distinct manifestations of HIV-associated lung function impairment. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT02382822; URL: www. CLINICALTRIALS: gov.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Respiratory Medicine, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Herlev,…
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev,…
- Department of Research, Boise Veterans Affairs Medical Center, Boise, ID.
- Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Den…
Förderung
- Independent Research Fund Denmark
- Gilead Sciences Inc
- Copenhagen University Hospital Rigshospitalet
- Region Hovedstaden
- Svend Andersen Foundation
- Aase and Ejnar Danielsens Foundation
- Danmarks Frie Forskningsfond
- Novo Nordisk Foundation
Zitieren
APA
Heidari, S. L., Loft, J. A., Çolak, Y., Afzal, S., Nordestgaard, B. G., Benfield, T., Kunisaki, K. M., Nielsen, S. D., & Ronit, A. (2026). Prevalence and Risk Factors of Preserved Ratio Impaired Spirometry in People With HIV and Matched Population Control Participants. CHEST, 170(5), 1532-1542. https://doi.org/10.1016/j.chest.2026.05.044
Vancouver
Heidari SL, Loft JA, Çolak Y, Afzal S, Nordestgaard BG, Benfield T, et al. Prevalence and Risk Factors of Preserved Ratio Impaired Spirometry in People With HIV and Matched Population Control Participants. CHEST. 2026;170(5):1532-1542. doi:10.1016/j.chest.2026.05.044
BibTeX
@article{Heidari2026,
author = {Heidari, Safura-Luise and Loft, Josefine Amalie and Çolak, Yunus and Afzal, Shoaib and Nordestgaard, Børge G and Benfield, Thomas and Kunisaki, Ken M and Nielsen, Susanne Dam and Ronit, Andreas},
title = {Prevalence and Risk Factors of Preserved Ratio Impaired Spirometry in People With HIV and Matched Population Control Participants},
journal = {CHEST},
year = {2026},
volume = {170},
number = {5},
pages = {1532--1542},
doi = {10.1016/j.chest.2026.05.044}
}
EUVIMED